Contemporary Clinical Trials

Aims & Scope

Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics.

Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics.

Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published.

Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	2.00

Journal Rank

Year	Value
2024	4788

Journal Citation Indicator

Year	Value
2024	1865

SJR (SCImago Journal Rank)

Year	Value
2024	1.005

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	79

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Meta-analysis in clinical trials revisited

  Citation: 2073

  Authors: Rebecca, Nan

• Random-effects model for meta-analysis of clinical trials: An update

  Citation: 1934

  Authors: Rebecca, Raghu

• Design and analysis of stepped wedge cluster randomized trials

  Citation: 1112

  Authors: Michael A., James P.

• Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study — A large observational study of the determinants of fracture in older men

  Citation: 646

  Authors: Eric, Janet Babich, Elizabeth, Jane, Steven, Kristine, Cora, Peggy M., Robert, Lynn M., Joan, Kathy, Sherry, Marcia L., Katie

• Advances in the meta-analysis of heterogeneous clinical trials I: The inverse variance heterogeneity model

  Citation: 491

  Authors: Suhail A.R., Jan J., Shahjahan, Lukman, Gail M.

• Overview of recruitment for the osteoporotic fractures in men study (MrOS)

  Citation: 488

  Authors: Janet Babich, Peggy Mannen, Mary Lou, Loretta, J. Phillip, Eileen, Romelia Ramírez

• The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

  Citation: 434

  Authors: JoAnn E., Shari S., I-Min, Nancy R., Michelle A., David, Elaine, Jean G., Eleanor, Jennifer, Shumin M., Julie E.

• The use of unequal randomisation ratios in clinical trials: A review

  Citation: 271

  Authors: J.C., S., J.N.V., D.J.

• Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial

  Citation: 255

  Authors:

• Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review

  Citation: 233

  Authors: Caren, Joyce E., Jill Dumbauld, Patricia J., Dawn, Mimi, Winston P.

---